Greg Carney

Pharmacoepidemiologist with the Therapeutics Initiative, @UBC. PhD in Pharmacology. Partner at Wildlife Intel. #epitwitter #RxEpi #MachineLearning

[Greg Carney @GregCarney]

New research exploring the complexity of #diabetes prescribing in BC

Highlights
*⬇️baseline A1C values
* Alarming⬇️1st-line metformin
* SU remains 2nd-line favorite

#DiabetesAwarenessMonth
Treatment pattern trends of medications for type 2 diabetes
https://t.co/JQ1WgrO9rw

[Greg Carney @GregCarney]

Nearly 30% of older adults with type 2 diabetes in BC may be overtreated, despite already having A1C ≤7%.
Our new study uses machine learning + clinical expertise to identify who’s most at risk. #Diabetes #Deprescribing

@Drug_Evidence

https://t.co/Z7mUb1DcVl

[Jesús Palacio @je_pala]

Obstáculos y facilitadores para reducir la solicitud innecesaria de analíticas de hormonas tiroideas https://t.co/RTu8eNFaUV en @BMJ_Qual_Saf #SegPac

[Therapeutics Initiative (TI) @Drug_Evidence]

Our @drug_evidence team has worked so hard on Portraits https://t.co/a2p6RXvv1n and we have RCT evidence that it improves #prescribing patterns.

How excited, grateful, & proud we feel to be recognized by @UBC Medicine for our innovation in #CME

https://t.co/dsR7IEObEW

[Therapeutics Initiative (TI) @Drug_Evidence]

🆕 Barriers and facilitators to appropriate thyroid function testing: a provincial mixed-methods study

https://t.co/wbAg26Ecf5

#labtesting #overdiagnosis #MedEd

[Greg Carney @GregCarney]

10,200 BC patients took Paxlovid. Nearly half had side effects. Most mild - some serious and ending in hospital care. Here's what we found:
https://t.co/kseG2v769N

[Brad Langford @BRxAD]

Peer comparison audit & feedback works to improve antibiotic prescribing in primary care. Now, health system leaders and policy-makers must take decisive steps to integrate this strategy into the healthcare system.
https://t.co/rJzFoX4jbI
🆕@BMJ_Qual_Saf 👏@DrKevinSchwartz

[Greg Carney @GregCarney]

Results are in!

The UBC Therapeutics Initiative operates one of the most innovative Audit & Feedback programs in the world. You can check it out here: https://t.co/jNQMQ2UC1Y

https://t.co/B5ixy00c9n

[Therapeutics Initiative (TI) @Drug_Evidence]

🆕UBC TI Therapeutics Letter 1⃣4⃣6⃣:

#Apixaban is safer and more effective than rivaroxaban for non-valvular atrial fibrillation
👉🏽https://t.co/IB3bHe9i8u

#MedEd #medsafety #prescribing #DOACs #NVAF

[Greg Carney @GregCarney]

Prescription ranitidine use in 6 Canadian provinces. Among younger adults prevalence was lowest in BC. Across all 6 provinces, females more commonly dispensed an H2RA.

https://t.co/mVWPUb5dRd

[Greg Carney @GregCarney]

@Drug_Evidence

[Greg Carney @GregCarney]

Treatment of adult ADHD has increased over 1600% since 2004!

#ADHD
@Drug_Evidence

https://t.co/2JLjDP3koX

[Therapeutics Initiative (TI) @Drug_Evidence]

🧵How should we diagnose & manage adult attention deficit hyperactivity disorder (ADHD)?

1/ Our UBC TI Therapeutics Letter 144 examines the evidence for pharmacotherapy and non-drug treatments for adult #ADHD
👉🏽https://t.co/vuJGPTSnNi

#MedEd #MedTwitter #diagnosis #prescribing

[Dr Jessica Otte, CCFP, FCFP🇨🇦 - palliative/FP @LessIsMoreMed]

We @Drug_Evidence did a thing.
Because getting your prescribing feedback along with the latest evidence = best care for British Columbians!
https://t.co/NvHllPXxb3

#TCMPed #feedback @BCFamilyDoctors @BCCFP @UBCCPD shout out to @PathwaysBC @HDCBC_Canada @DoctorsOfBC FPSC+ more!

[Therapeutics Initiative (TI) @Drug_Evidence]

🚨 Calling all BC #FamilyDoctors + #NPs 🩺

Improve pt care with distilled evidence + #prescribing feedback💊 = UBC Therapeutics Initiative Portraits

Register online by Oct 14 & you'll be entered to win an iPad!

Register: https://t.co/aWvNAcjp1S
Info: https://t.co/gGs0416LSy

[Greg Carney @GregCarney]

That’s a wrap at #icpe2023 where I presented 3 research posters from the UBC Therapeutics Initiative @Drug_Evidence. #Paxlovid effectiveness, +results from our highly successful Prescriber Portrait program. The scientific program this year was second to none!

[Therapeutics Initiative (TI) @Drug_Evidence]

🆕 #Prescribing Portraits publication! 🚨

Trial finds personalized prescribing feedback to family physicians + population data on antibiotic resistance, with a simple therapeutic recommendation, can significantly improve prescribing of #antibiotics

👉🏽https://t.co/aGssqjK3tl

[Therapeutics Initiative (TI) @Drug_Evidence]

Multi-site population-based cohort study finds HCTZ not associated with an overall increased risk of keratinocyte carcinoma compared with ACEIs or CCBs, although increased risks were observed with longer durations

👉🏽https://t.co/TIWVr7lT25

#medsafety #prescribing

[Therapeutics Initiative (TI) @Drug_Evidence]

UBC TI Therapeutics Letter 1⃣4⃣1⃣ : #Paxlovid in BC

🔴Efficacy evidence from unvaxxed high-risk pts in 2021 may be irrelevant to pts in 2023

🟡Benefits unproven in lower-risk #COVID19 pts

🟢Evidence of some benefit in high-risk groups in BC during 2022

https://t.co/XAhED8BBcz

[Therapeutics Initiative (TI) @Drug_Evidence]

Check out our @YouTube channel to view our #MedEd, #BetterPrescribing & #PatientExperience videos 🤩🧑🏾‍💻

👉🏽Watch+Subscribe: https://t.co/r0qhq7ymga

#BetterHealth #Prescribing #MedTwitter #FOAMed #Deprescribing #ResearchMethods

[Therapeutics Initiative (TI) @Drug_Evidence]

🆕 UBC TI Therapeutics Letter 1⃣4⃣1⃣ : #Paxlovid in BC

🔴Efficacy evidence from unvaxxed high-risk pts in 2021 may be irrelevant to pts in 2023

🟡Benefits unproven in lower-risk #COVID19 pts

🟢Evidence of some benefit in high-risk BC groups during 2022

https://t.co/XAhED8BBcz